LAMEA Virology Specimen Collection Market By Sample, By Product Type, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The Latin America, Middle East and Africa Virology Specimen Collection Market is expected to witness market growth of 2.1% CAGR during the forecast period (2021-2027).

A significant number of advancements in diagnostic virology have occurred in recent years, including improvements in cell culture methods and the creation of viral antigen (Ag) and nucleic acid (NA) assays. Pre-analytical processes, such as specimen selection, collection, transport, and processing, are critical for accurate test results, regardless of the detection technology used. 

Rapid diagnostic tests have exploded in popularity because they deliver more accurate and faster results, enhance prescribing, and shorten hospital stays. Clinicians trust these tests to help them navigate a pandemic of extremely dangerous viruses like the Middle East respiratory syndrome coronavirus, Ebola, and others. This increases the frequency with which bacterial and viral specimen collecting items are used for fast diagnostic tests.

According to data shared by the Centre for Disease Control and Prevention, in 2016, 28,600 cases of the Ebola virus were found across South Africa and neighbouring countries while 11,325 people died due to the virus. This data shows the risk of the emergence of viruses as well as the requirement for virology specimen collection technologies across LAMEA. Hence, these factors are likely to create lucrative growth opportunities for the regional virology specimen collection market during the forecasting period. 

The Brazil market dominated the LAMEA Virology Specimen Collection Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $129.7 million by 2027. The Argentina market is expected to showcase a CAGR of 2.6% during (2021 - 2027). Additionally, The UAE market is poised to grow a CAGR of 1.8% during (2021 - 2027).

Based on Sample, the market is segmented into Nasopharyngeal Samples, Throat Samples, Cervical Samples, Nasal Samples, Blood Samples, Oral Samples, and Others. Based on Product Type, the market is segmented into Viral Transport Media, Specimen Collection Tubes, Blood Collection Kits and Swabs. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trinity Biotech Plc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, DiaSorin S.p.A., Vircell S.L., Quidel Corporation, Titan Biotech Ltd., Puritan Medical Products, Copan Italia s.p.a., and Hardy Diagnostics.

Scope of the Study

Market Segments Covered in the Report:

By Sample

• Nasopharyngeal Samples
• Throat Samples
• Cervical Samples
• Nasal Samples
• Blood Samples
• Oral Samples, and
• Others

By Product Type

• Viral Transport Media
• Specimen Collection Tubes
• Blood Collection Kits and
• Swabs

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Trinity Biotech Plc
• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• DiaSorin S.p.A.
• Vircell S.L.
• Quidel Corporation
• Titan Biotech Ltd.
• Puritan Medical Products
• Copan Italia s.p.a.
• Hardy Diagnostics

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free